Nucleation of ordered solid phases of proteins triggers numerous phenomena in laboratory, industry, and in healthy and sick organisms. Recent simulations and experiments with protein crystals suggest that the formation of an ordered crystalline nucleus is preceded by a disordered high-density cluster, akin to a droplet of high-density liquid that has been observed with some proteins; this mechanism allowed a qualitative explanation of recorded complex nucleation kinetics curves. Here, we present a simple phenomenological theory that takes into account intermediate high-density metastable states in the nucleation process. Nucleation rate data at varying temperature and protein concentration are reproduced with high fidelity using literature values of the thermodynamic and kinetic parameters of the system. Our calculations show that the growth rate of the near-critical and supercritical ordered clusters within the dense intermediate is a major factor for the overall nucleation rate. This highlights the role of viscosity within the dense intermediate for the formation of the ordered nucleus. The model provides an understanding of the action of additives that delay or accelerate nucleation and presents a framework within which the nucleation of other ordered protein solid phases, e.g., the sickle cell hemoglobin polymers, can be analyzed.
I. INTRODUCTION
The formation of protein ordered phases is of interest to many scientific and technological areas: structural biology, [1] [2] [3] patho-physiology of protein condensation diseases, [4] [5] [6] production of protein pharmaceutical preparations, 7, 8 etc., and a deeper understanding of the underlying mechanisms is expected to facilitate progress in these areas.
The phase diagrams of protein solutions differ from those of simple substances, such as argon. The significant factor underlying this difference is the range of attraction between molecules: [9] [10] [11] this range is determined by the size of the solvent molecules 12 ͑at the typically used ionic strengths of ജ0.1 M the electrostatics is screened and the Deriaguine-Landau-Veervey-Overback theory does not apply 13, 14 ͒, smaller by at least an order of magnitude than the protein molecules' sizes. As a result, in protein solutions the triple point disappears and the liquid-liquid ͑L-L͒ phase separation is submerged below the solution-crystal equilibrium. 15, 16 Phase diagrams with a L-L separation line with a critical point lying below a smooth liquidus and a solidus lines have been found for several proteins. [17] [18] [19] [20] [21] An investigation of the crystal nucleation mechanisms using the protein lysozyme revealed an unusual dependence of the rate of homogeneous nucleation on temperature: as the temperature is lowered from the equilibrium, the dependence passes through a maximum in the vicinity of liquid-liquid phase boundary, 22 Fig. 1. Another unusual result with the same system was that as supersaturation is increased, the nucleus size decreases and reaches one molecule. 23 This transition occurs at conditions that differ by 1.0°C-1.5°C ͑or ϳ10-15 mg ml −1 ͒ from the L-L coexistence line in the ͑temperature, protein concentration͒ plane and indicates that the nucleation free-energy barrier becomes less than the thermal energy and the rate of nucleation is solely limited by the kinetics of growth of the near-critical clusters. [24] [25] [26] These two observations contradict the assumptions and predictions of the classical nucleation theory. 27 Prompted by computer simulations 28 and density functional calculations 29 results in the vicinity of the L-L critical point, the above unusual behavior of the nucleation rate was explained by the presence of a dense liquid intermediate in the nucleation reaction pathway, Fig. 2 . 22, 30 Since the nucleation rate maximum is consistently reached above the L-L coexistence line, it was concluded that a dense-liquid-like droplet, unstable or metastable with respect to the low density solution, serves as an intermediate in that region, Fig.  2 . 30 Similar interpretations of these results were offered in several theoretical and computational investigations of protein crystallization. [31] [32] [33] Note also that the protein nucleation is a complex phenomenon that cannot be described by a single order parameter. Thus Fig. 2 is a simplified formal presentation of a free-energy landscape of the system, and the nucleation reaction coordinate might include several order parameters.
In this paper we develop a simple phenomenological model of protein crystallization via an intermediate liquid state. Our goal is a quantitative understanding of the dependence of nucleation on temperature and concentration using parameters that can be measured experimentally.
II. THE MODEL

A. The nucleation rate law
Our main assumption is that in the supersaturated dilute solution a liquidlike cluster is formed with a temperaturedependent and protein-concentration-dependent rate u 0 ͑C , T͒. This cluster can dissociate back into the solution with rate u 1 ͑T͒, or it can transform into an ordered crystal nucleus with rate u 2 ͑T͒. The crystal nucleus irreversibly grows to a macroscopic ordered phase. These processes can be formally described by the following rate scheme:
where state 0 corresponds to the dilute solution, state 1 is the intermediate dense liquid cluster, and state 2 is the final crystalline phase. These three states correspond to the minima in the energy landscape picture in Fig. 2 . The thermodynamic and kinetic parameters of the intermediate and the depth E 1 of the second minimum determine the nucleation rate resulting form this model. For all temperatures above the critical T c for L-L separation, we assume that the system, via concentration fluctuations, selects the intermediate state leading to fastest nucleation of crystals; E 1 Ͻ E 0 so that the intermediate is metastable or unstable with respect to the dilute solution. At T Ͻ T c , we test two possibilities: ͑i͒ state 1 is the same as the dense phase at this temperature; ͑ii͒ state 1 is selected according to the same criteria as at T Ͼ T c . E 1 becomes greater than E 0 not at T c but at T L-L at which the chosen dilute solution is in equilibrium with a dense liquid. In all cases, the intermediate has a higher free energy than the final crystalline state.
If we define P i ͑t͒ as a probability to find the system in state i =0,1, or 2 at time t, then a parameter = ͐ 0 ϱ t͓dP 2 ͑t͒ / dt͔dt determines the mean time to create one crystalline nucleus in a steady state process. Thus, the parameter represents a mean first-passage time for the transition from state 0 to state 2 and is given by
The rates u 0 , u 1 , and u 2 depend on temperature as u i ͑T͒ = U i exp͑−E i / k B T͒, i =0,1,2. As a first simple approximation, the steady-state nucleation rate J can be calculated as J = −1 . We get for J
͑3͒
This is a general expression for the nucleation rate with one intermediate state. Note that it differs significantly from a classical nucleation theory formula with a single temperature-dependent exponent. 27 Next, we divide the numerator and denominator on the left side of Eq. ͑3͒ by U 0 exp͑−E 0 / k B T͒, and define a Gibbs free-energy change for the formation of the intermediate Equation ͑4͒ shows that J does not explicitly depend on the size of the barrier for decay of the dense liquid intermediate: even if E 1 = 0 and the intermediate is unstable ͑this corresponds to a typical density fluctuation͒, the expression for J does not change.
B. The maximum in the nucleation rate
Assuming that U 1 / U 0 , U 2 , and E 2 are not functions of temperature, we solve the equation ͑‫ץ‬J / ‫ץ‬T͒ T * = 0 and find that the nucleation rate reaches a maximum at a temperature T * determined from
If ⌬G is independent of temperature, this expressions yields a T * which is not physically meaningful. For a more realistic description, we allow E 0 and E 1 to change with temperature. We assume that their difference ⌬G =0 at T L-L , and ⌬G / k B T changes linearly with T both above and below T L-L . To find the increment of this dependence, we assume that it equals the temperature increment of the dependence of the free-energy change
Integrating numerically the Gibbs-
we get A = 0.0666. Using the same A for ⌬G / k B T at T both above and below T L-L , we find that B = −18.9 ensures that ⌬G =0 at T L-L for C = 50 mg/ ml, while B = −19.2 for C = 80 mg/ ml, the two concentrations of the data in Fig. 1 . Then, from Eq. ͑5͒ with E 2 ϳ k B T, T * ϳ 170 K, far below that observed experimentally. More importantly, we find ͑model results not shown͒ that the nucleation rate J egresses toward the maximum at T * upon temperature decrease not by a steep exponential as in Fig. 1 , but rather by a weak sublinear function.
C. Using the system parameters
The above considerations show that a model that could adequately describe the data in Fig. 1 should account for the physical specificity of the system and of the chosen kinetic model, as well as for the temperature dependence of E 2 .
A crucial element of the model is the nature of the intermediate state. We assume that is akin to the dense liquid and exists at the same temperature as the dilute solution. This allows us use the above linear dependence ⌬G͑T͒ on both sides of T L-L , and this is equivalent to assuming that E 1 0 at T Ͼ T L-L , i.e., the intermediate is not a mere density fluctuation. The alternative assumption would lead to a break in ⌬G at T L-L and a discontinuity in the J͑T͒ dependence. The absence of such discontinuity in Fig. 1 suggests that the intermediate is metastable and has a finite lifetime. Experimental evidence of the existence of such a metastable intermediate has now been found for three protein, including lysozyme, data which are modeled here, using dynamic light scattering. 38 While these tests show that the size of the metastable liquid droplets is from a few tens to a few hundred nanometers, neither this nor any other technique can provide an estimate of the protein concentration in these droplets. We assume that at each temperature, an intermediate state with a concentration C 1 that does not depend on the dilute solution concentration is selected and that C 1 obeys
Below, we show that the nucleation rate law depends only weakly on the exact values of A 1 and B 1 as long as the resulting C 1 in the range T Ͻ T c is in the vicinity of the equilibrium concentration of the dense liquid. The C 1 ͑T͒ dependencies tested below are depicted in Fig. 3 .
The preexponential factor U 2 in Eq. ͑4͒ accounts for the kinetics of growth of ordered clusters within the dense liquid droplet, and it should depend on the temperature, concentration, and viscosity within the droplet. In analogy to the preexponential factors for nucleation of solids in melts, we assume that U 2 is proportional to C 1 and T and inversely proportional to viscosity in the dense liquid at concentration C 1 ͑Ref. 39͒,
where k 2 is a kinetic constant.
We assume that follows the same dependence in the dilute solution and in the dense liquid and represent ͑C , T͒ as the product of the Andrade-Eyring expression for the temperature dependence 40 and an empirical expression for the concentration dependence. 41 We get
where 0 is the viscosity of the solvent, ͓͔ is the viscosity increment at low concentrations, E is the Arrhenius-type temperature factor for the viscosity, and k is a parameter typically determined by fitting ͑C͒ dependencies to Eq. ͑8͒;
k takes values form 1 to 10. 41 The former three parameters can be determined by fitting Eq. ͑8͒ to the data on the viscosity of low-concentration lysozyme solutions at various temperatures. 42 Thus, in all cases 0 = 0.051 cP, ͓͔ = 0.0045 mg −1 ml, and E = −7.3 kJ/ mol. The resulting ͑C , T͒ curves with k = 4 are shown in Fig. 4 . As expected, they diverge as C approaches 600 mg ml −1 with a corresponding volume fraction 0.49, the noninteracting hard sphere limit. 41 The expression for u 0 in Eq. ͑4͒ above is the rate of nucleation of dense liquid droplets and thus the preexponential factor U 0 is a linear function of the dilute solution concentration. 43, 44 Since we know nothing about U 1 we assume that it is constant, so that the ratio U 1 / U 0 = 1 for C =50 mg ml −1 and 50/ C for other dilute solution concentrations C.
D. The barrier E 2
The steep dependence of J on the deviation of the temperature from the value at solution-crystal equilibrium suggests that the barrier E 2 should be a decreasing function of temperature. Furthermore, comparing the temperatures of the maxima in Fig. 1 at the two studied concentrations to locations in the ͑C , T͒ plane, where the nucleus size decreases to one molecule and the nucleation barrier vanishes, 23, 38 we find that they coincide. In analogy to the similar phase locations in phase diagrams of fluids, [24] [25] [26] we assign this temperature to the crystallization spinodal and denote it with T sp . Note that this spinodal is kinetically determined and denotes a location where the solution loses stability with respect to a combination of concentration and structure fluctuations. This differs from the spinodal ͑or pseudospinodal 45 ͒ for L-L separation introduced in Ref. 37 , which may be related to stability loss by concentration fluctuations alone.
We assume that between T e and T sp , E 2 smoothly decreases from infinity to zero, and in analogy to a recently introduced law, 46 follows a ⌬T −2 dependence,
͑9͒
The parameter E * is determined from the following considerations. At T higher than T L-L by several degrees, the nucleation barrier should be Ϸn * ⌬ / 2, where n * is the nucleus size and ⌬ is the thermodynamic supersaturation. Since ⌬ / k B T Ϸ 2-3 and n * is between 4 and 10, 23 the barrier should be several k B T units. Using the values of T e and T sp from Table I and assuming E * = 15 000 kJ mol −1 , we get the E 2 ͑T͒ dependencies shown in Fig. 5 , which fulfill this requirement. Note that E * corresponds to the nucleation barrier E 2 only in the immediate vicinity of T e , where E 2 approaches infinity. Thus, the high value of E * allows a strong dependence of E 2 on ⌬T via Eq. ͑9͒ that results in E 2 Ϸ 50 kJ mol −1 at T = 300 K, where nucleation is still extremely slow, see Fig. 1 .
III. MODEL EVALUATION
A. Pure solutions
Lysozyme solutions represent a unique protein system, for which the available data provide values or reasonable estimates for most of the parameters of the above model. The Table I , we fit the model predictions to the data at C =50 mg ml −1 in Fig. 1 . The values of k 2 and k yielding the best fit are shown in Table I . Note that all values of k are within the range 1 -10 found with other solutions for which the viscosity at high concentration has been studied. 41 Using the characteristic temperatures for C =80 mg ml −1 and the same kinetic parameters as those for C =50 mg ml −1 , we evaluated the model for the former protein concentration. Figure 1 shows that the correspondence between the model prediction and the actual data for C =80 mg ml −1 is remarkably good.
B. The concentration C 1 in the dense liquid intermediate
To evaluate the significance of the accuracy of the guess of the concentration within the dense liquid intermediate, we evaluated the dependence J͑C 1 ͒ stemming from Eqs. ͑4͒, ͑7͒, and ͑8͒ at several T = const. We got very shallow maxima at C 1 's near and to the right of the L-L coexistence line. The increase in J to the left of these maxima is due to the dependence in Eq. ͑7͒, while the decrease to the right of maxima, to Eq. ͑8͒. The shallowness of the maxima indicates that the exact selection of C 1 is not crucial for the resulting value of the nucleation rate. Since the nucleation follows the fastest pathway, we chose the parameters A 1 = −10 and B 1 = 3270 in Eq. ͑6͒ that ensure C 1 values in the region of these maxima.
As a second test of the significance of C 1 , we evaluated the model with different values of the parameters A 1 and B 1 in Eq. ͑6͒. If the tested C 1 ͑T͒ dependence runs near to the case modeled above, such as cases 6 and 7 in Table II and Fig. 3 , slight adjustments of the values of the parameters k and E * within their acceptable physical ranges ensure a perfect fit of the model to the experimental results for both C =50 mg ml −1 and C =80 mg ml −1 . However, if the tested C 1 ͑T͒ dependence lay far from case modeled above, such as case 8 in Table II and Fig. 3 , the model could not be fit to any of the data sets because of the high values in the high-concentration region: compare Figs. 3 and 4 . In a special case 5 in Table II , C 1 ͑T͒ was chosen to cross the L-L coexistence line and the model calculations were carried out assuming that C 1 belongs to that line if the linear dependence lies beneath it. The model yielded a second maximum in the J͑T͒ dependence at T where C 1 ͑T͒ crosses the L-L coexistence line, which, apparently, is absent in the experiential data in Fig. 1 .
This latter strong deviation indicates that the intermediate differs from the macroscopic dense liquid phase. On the other hand, the dependence of C 1 ͑T͒ was introduced assuming that the intermediate is similar to the dense liquid. These are not necessarily contradictory statements. We note that small clusters of a phase may have different properties than the macroscopic phase itself, as suggested by Gibbs.
46-48
Thus, it is likely that if the intermediate clusters are allowed to grow, they will become macroscopic dense liquid droplets and the suggestion that the intermediate is similar to the dense liquid phase is still valid.
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C. The effects of glycerol and polyethylene glycol on the nucleation rate
The above model provides a framework for the understanding of the experimentally observed effects of two additives, glycerol and polyethylene glycol 8000 ͑PEG͒ on the nucleation kinetics: 22 it allows discrimination between the effects of the additives on the solution thermodynamics from those on the nucleation kinetics. The experimental results show that glycerol shifts the temperatures of solution-crystal equilibrium and of L-L coexistence and delays the nucleation rate. The low amount of PEG used, 0.2%, does not affect the phase diagram, however, it leads to significant acceleration of the nucleation rate. 22 The experimental results in the presence of glycerol are compared to the model predictions with three sets of parameters. The dashed line in Fig. 6͑a͒ shows that if the effects of glycerol were limited to the effects on solution thermodynamics, the nucleation rate would have been suppressed very significantly. However, the increase of k 2 necessary to fit the model predictions to the experimental data, see Table I , suggest that glycerol significantly accelerates the kinetics of growth of the ordered clusters within the dense liquid intermediate. Furthermore, the scaling factor for E 2 was reduced by 33% indicating that glycerol leads to lower barriers for the nucleation of the ordered phase. The effects of PEG are well modeled by a higher k 2 again suggesting an acceleration of the growth rate of the critical clusters.
We refrain from offering a molecular-level interpretation of the decrease in the barrier for nucleation of ordered clusters within the dense liquid intermediate in the presence of glycerol. However, the accelerated kinetics of growth of the clusters in the presence of both glycerol and PEG is very interesting. We draw an analogy to the ϳ ten-fold acceleration of the kinetics of step growth on insulin crystals in the presence of acetone. 49 This acceleration was attributed to the destruction of the water shells around the insulin molecules in solution by acetone evidenced independently in Ref. 50 . The link between the two is the finding that the kinetics of growth of ordered solid phases from solution is limited by the necessity to push structured waters out of the interstice between the incoming molecule and those already in the crystal. 37 Glycerol and PEG are similar to acetone in that all three are amphiphylic molecules. Thus, we conclude that the only effect of PEG and the strongest effect of glycerol on the nucleation kinetics occur via the destruction of the water shells of the molecules in the dense liquid precursor.
D. The dependence of the nucleation rate on protein concentration at constant temperature
The data on J͑C͒ at T = 285.7 K in Fig. 6͑b͒ is split into two regions. At C Ͻ 33 mg ml −1 , J increases quasiexponentially and the nucleus size n * = 4 molecules. At C Ͼ 33 mg ml −1 , J is a weak function of C and n * = 1. In analogy to the spinodal T sp above, we introduce C sp =33 mg ml −1 . To model the dependence J͑C͒, we use the values of ⌬G, C 1 , and at this temperature. We use
A good fit of the model results to the experimental data required a slight increase of k 2 from 0.266, see Table I , to 0.2793 at C Ͻ C sp . Because of the abrupt change of E 2 at C sp , k 2 is needed to be changed to 1.596ϫ 10 −6 for C Ͼ C sp . It seems reasonable to assign the necessity of the increase of k 2 at C Ͻ C sp to the accumulation of inaccuracies in the values of ⌬G, C 1 , and . Furthermore, the change of k 2 at C sp is due to the jump in the size of the nucleus, reflected in the J͑C͒ data. Such jumps are also a part of the J͑T͒ data in Fig. 1 ; however, the driving force for the n * jumps is the decreasing ⌬, which is a more sensitive function of T than C. The density of J͑T͒ data points is insufficient to reveal the interruptions in the n * ͑T͒ dependence, and the use of a smooth E 2 ͑T͒ is appropriate. This smooth E 2 ͑T͒ allowed the use of a single value of the adjustable parameters k 2 even below T sp . Thus, the good fit of the model results of the data in Fig. 6͑b͒ represent another success of the model.
E. The contribution of the dense liquid intermediate to faster nucleation rates at lower temperatures
As a rough estimate of this contribution, we evaluated the denominator in the nucleation rate law Eq. ͑4͒ in Fig. 7 ; this denominator would not be present in a single step nucleation. Due to our arbitrary choice of U 0 and U 1 , the absolute values of this expression are meaningless. However, we see that as T is lowered, the denominator contributes factors of ϳ5 -7 in the response of J to T. This contribution enhances at T Ͼ T sp the effect of lower E 2 . At T Ͻ T sp , the acceleration due to lower ⌬G is overwhelmed by the deceleration due to higher viscosity within the intermediate. Table I , all other parameters are as in case 1 in Table I ; dotted line is for T e and T sp are as in case 3 in Table I , k 2 = 1.862, all other parameters are as in case 1 in Table I ; solid line is for all parameters as in case 3 in Table I . For PEG: solid line is for case 4 in Table I 
IV. SUMMARY AND CONCLUSIONS
We have developed a simple phenomenological model describing the kinetics of nucleation of protein ordered solid phases from solution via a metastable intermediate. The model allows accurate predictions of the complex dependencies of the nucleation rate of crystals of the protein lysozyme using a single adjustable kinetic parameter and a reasonable guess of one materials parameter. The good correspondence between the model results and the experimental data supports the following features of the nucleation mechanism.
͑i͒
The intermediate is similar to the dense liquid existing in lysozyme solutions. ͑ii͒
The intermediate is metastable with respect to the dilute solution, i.e., a barrier for its decay exists and it is not a simple density fluctuation. ͑iii͒ The rate-determining step in the nucleation mechanism is the formation of an ordered cluster within the dense liquid intermediate. ͑iv͒ The viscosity within the metastable dense liquid droplet is a crucial parameter in the kinetics of nucleation of ordered solid phases.
The model allows discrimination between the thermodynamic and kinetic effects of additives that slow down or accelerate nucleation. It suggests that the amphiphylic character of the two tested additives accelerate the kinetics of growth of the near-critical ordered clusters in the dense liquid droplets by destroying the water structures around the protein molecules.
Future theoretical work should address the case of two step nucleation, in which the second step, ordering, is not the rate limiting one. Other potential avenues include understanding of the means to enhance the ordering employed by experimentalists: external fields, shear flow, etc. Experimentalists should provide data on the behavior of protein solution viscosity at high solution concentrations, as well as, of course, data on the nucleation rates with other protein and nonprotein materials.
